MedTrace Logo

Efficacy of a Pacemaker Algorithm in Promotion of the Intrinsic Heart Activity.

NCT00156741 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2011-08-02

No results posted yet for this study

Summary

The purpose of this study is to provide evidence that the Refined Ventricular Pacing Algorithm leads to clinically relevant reduction (at least 50% reduction) of the incidence of ventricular pacing.

Conditions

  • Bradycardia; Sick Sinus Syndrome, AV Block

Interventions

DEVICE

Vitatron C50 D Model C50A2 of Vitatron C60 DR model C60A2

PROCEDURE

Required pacemaker setting

Sponsors & Collaborators

  • Medtronic BRC

    lead INDUSTRY

Principal Investigators

  • Ludwig Binner, MD · Universitätsklinikum Ulm, Ulm, Germany

  • Chris van Groeningen, MD · Vitatron B.V., Arnhem, The Netherlands

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-04-30
Completion
2006-04-30

Countries

  • Austria
  • Czechia
  • Denmark
  • Finland
  • Germany
  • Italy
  • Netherlands
  • Russia
  • Sweden
  • Switzerland
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00156741 on ClinicalTrials.gov